HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Furukawa Selected Research

Dopa-responsive Dystonia

7/2003Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation.
1/2001Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations.
6/2000Scoliosis in a dopa-responsive dystonia family with a mutation of the GTP cyclohydrolase I gene.
4/2000Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Furukawa Research Topics

Disease

21Neoplasms (Cancer)
08/2009 - 02/2000
10Carcinogenesis
01/2010 - 07/2000
9Leukemia
03/2013 - 04/2001
9Colorectal Neoplasms (Colorectal Cancer)
01/2010 - 01/2000
9Colonic Neoplasms (Colon Cancer)
01/2006 - 01/2000
5Carcinoma (Carcinomatosis)
01/2019 - 01/2000
5Hepatocellular Carcinoma (Hepatoma)
08/2006 - 03/2000
4Dopa-responsive Dystonia
07/2003 - 04/2000
4Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
08/2001 - 03/2000
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/2014 - 04/2001
3Philadelphia Chromosome
03/2013 - 04/2001
3Lymphoma (Lymphomas)
10/2010 - 03/2000
3Hyperplasia
08/2001 - 08/2000
3Atherosclerosis
12/2000 - 01/2000
2Neoplasm Metastasis (Metastasis)
01/2019 - 09/2001
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2013 - 04/2001
2Psoriasis (Pustulosis Palmaris et Plantaris)
12/2009 - 05/2001
2Skin Diseases (Skin Disease)
12/2009 - 05/2001
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2008 - 05/2007
2Infarction (Infarctions)
09/2006 - 11/2001
2Sporadic Creutzfeldt-Jakob Disease
02/2005 - 02/2003
2Rupture
11/2001 - 01/2001
2Hypoxia (Hypoxemia)
10/2001 - 02/2001
2Vascular System Injuries
09/2001 - 12/2000
2Esophageal Neoplasms (Esophageal Cancer)
09/2001 - 02/2000
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
02/2001 - 03/2000
2Adenoma (Adenomas)
08/2000 - 05/2000
1Cognitive Dysfunction
01/2018
1Infections
09/2017
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
06/2014
1Marfan Syndrome (Marfan's Syndrome)
05/2014
1Aortic Dissection
05/2014
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2013
1Insulin Resistance
01/2013
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2013
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2010
1Necrosis
12/2009
1Ectodermal Dysplasia (Aplasia Cutis Congenita)
08/2009

Drug/Important Bio-Agent (IBA)

11Complementary DNA (cDNA)IBA
01/2010 - 06/2000
10Proteins (Proteins, Gene)FDA Link
10/2010 - 04/2000
10beta CateninIBA
11/2001 - 03/2000
5CytokinesIBA
12/2009 - 01/2001
4Small Interfering RNA (siRNA)IBA
03/2013 - 01/2006
4Methotrexate (Mexate)FDA LinkGeneric
05/2007 - 01/2001
3Histone Deacetylase InhibitorsIBA
12/2013 - 01/2006
3Histones (Histone)IBA
12/2013 - 04/2008
3Messenger RNA (mRNA)IBA
10/2010 - 01/2000
3EnzymesIBA
07/2002 - 04/2000
3TCF Transcription FactorsIBA
11/2001 - 07/2000
3CollagenIBA
11/2001 - 06/2001
3DNA (Deoxyribonucleic Acid)IBA
02/2001 - 04/2000
2Bortezomib (Velcade)FDA Link
06/2014 - 01/2009
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2014 - 05/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
06/2014 - 05/2007
2Imatinib Mesylate (Gleevec)FDA Link
03/2013 - 04/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2013 - 06/2001
2romidepsin (FK228)FDA Link
10/2010 - 01/2006
2Histone Deacetylases (Histone Deacetylase)IBA
10/2010 - 01/2006
2Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
12/2009 - 05/2001
2midostaurinIBA
05/2008 - 05/2007
2Cytarabine (Cytosar-U)FDA LinkGeneric
05/2007 - 09/2002
2Vincristine (Oncovin)FDA LinkGeneric
05/2007 - 04/2001
2Antineoplastic Agents (Antineoplastics)IBA
01/2006 - 01/2001
2Levodopa (L Dopa)FDA LinkGeneric
01/2001 - 03/2000
2LipidsIBA
01/2001 - 01/2000
2raltitrexed (D 1694)IBA
01/2001 - 01/2000
2Thymidylate SynthaseIBA
01/2001 - 01/2000
2AldosteroneIBA
08/2000 - 05/2000
2GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA
06/2000 - 04/2000
2ZincIBA
02/2000 - 01/2000
1auraptenIBA
01/2018
1coumarinIBA
01/2018
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
09/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
06/2014
1Proteasome InhibitorsIBA
06/2014
1Drug CombinationsIBA
06/2014
1Alkylating AgentsIBA
12/2013
1nilotinibFDA Link
03/2013
1Tyrosine Kinase InhibitorsIBA
03/2013
1Dasatinib (BMS 354825)FDA Link
03/2013
1LigandsIBA
03/2013
1Death Domain ReceptorsIBA
03/2013
1TNF-Related Apoptosis-Inducing LigandIBA
03/2013
1AdiponectinIBA
01/2013
1Valproic Acid (Depakote)FDA LinkGeneric
10/2010
1CD20 AntigensIBA
10/2010
1Rituximab (Mabthera)FDA Link
10/2010
1Carrier Proteins (Binding Protein)IBA
01/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2009
1Interferon-gamma (Interferon, gamma)IBA
12/2009
1Interleukin-4 (Interleukin 4)IBA
12/2009
1Stem Cell FactorIBA
12/2009
1Interleukin-6 (Interleukin 6)IBA
12/2009
1Xedar ReceptorIBA
08/2009

Therapy/Procedure

10Therapeutics
03/2013 - 02/2000
3Drug Therapy (Chemotherapy)
01/2001 - 02/2000
1Chemoradiotherapy
01/2019
1Immunotherapy
01/2019
1Cesarean Section (Caesarean Section)
05/2014
1Stem Cell Transplantation
03/2013